Canada markets open in 4 hours 3 minutes

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6300+0.0599 (+10.51%)
At close: 04:00PM EST
0.6320 +0.00 (+0.32%)
Pre-Market: 04:22AM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.5701
Bid0.0000 x 800
Ask0.6580 x 1200
Day's Range0.5662 - 0.6789
52 Week Range0.5400 - 3.7700
Avg. Volume1,798,949
Market Cap76.479M
Beta (5Y Monthly)0.93
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Agile Therapeutics Reports Third Quarter 2021 Financial Results

    Prescription Demand Growth Continues in the Third Quarter 2021 with a 61% Increase in Twirla Cycles Dispensed Twirla Refill Rates Continue to Grow by 86% in Third Quarter 2021 Company Advances Programs Focused on Increasing Demand for Twirla Management to Host Conference Call Today, Tuesday, November 2, 2021 at 4:30 p.m. EDT PRINCETON, N.J., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three mont

  • GlobeNewswire

    Agile Therapeutics to Report Third Quarter 2021 Financial Results and Provide Business Update on Tuesday, November 2, 2021

    Live Conference Call and Webcast at 4:30 p.m. ETPRINCETON, N.J., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report third quarter 2021 financial results after the market close on Tuesday, November 2, 2021 as follows: DateTuesday, November 2, 2021Time4:30 p.m. ETWebcast (live and archived)Events & PresentationsDial-in numbers(833) 979-2857 (U.S. toll-free) or (236) 714-2948Conference ID9988403 Investors intereste

  • GlobeNewswire

    Agile Therapeutics Applauds Congressional Chairs’ Letter to Biden Administration Requesting Enforcement of Contraceptive Access Under Affordable Care Act

    PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today applauded House Congressional Committee leaders in urging the Secretaries of U.S. Departments of Health and Human Services (HHS), Treasury, and Labor to enforce the law regarding women’s access to contraceptive methods as dictated by the Affordable Care Act (ACA). "We applaud the authors of the letter, Energy and Commerce Chairman, Frank Pallone Jr., Ways and Means Comm